An interim analysis of the Quality of Life, Effectiveness, Safety, and Tolerability (QU.E.S.T.) evaluation of mixed amphetamine salts extended release in adults with ADHD.

@article{Goodman2005AnIA,
  title={An interim analysis of the Quality of Life, Effectiveness, Safety, and Tolerability (QU.E.S.T.) evaluation of mixed amphetamine salts extended release in adults with ADHD.},
  author={David W. Goodman and Lawrence Ginsberg and Richard H. Weisler and Andrew J. Cutler and Paul S. Hodgkins},
  journal={CNS spectrums},
  year={2005},
  volume={10 12 Suppl 20},
  pages={26-34}
}
OBJECTIVE Evaluate safety and efficacy of mixed amphetamine salts extended release (MAS XR) in adults with attention-deficit/hyperactivity disorder (ADHD). METHODS 10-week interim analysis of the Quality of life, Effectiveness, Safety, and Tolerability (QU.E.S.T.) trial, an ongoing, 30-week, open-label, multicenter investigation of once-daily MAS XR (10-60 mg/day) in adults (>or=18 years of age) with ADHD in community practice settings. FINDINGS With up to 10 weeks of open-label MAS XR 10… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

Safety of stimulant treatment in attention deficit hyperactivity disorder: part II.

Expert opinion on drug safety • 2010
View 4 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 19 references

Dose-response efficacy of mixed amphetamine salts XR in adults with ADHD

SV Faraone, J Biederman, T Spencer
Poster presented at: 157th Annual Meeting of the American Psychiatric Association; May 1-6, • 2004

Mixed amphetamine salts XR in adults with ADHD: 18-month interim analysis

J. Biederman
Presented at: 157th Annual Meeting of the American Psychiatric Association; May 1-6, • 2004

Prevalence of adult ADHD in the United States: results from the National Comorbidity Survey Replication (NCS-R)

RC Kessler
Presentation at: 157th Annual Meeting of the American Psychiatric Association; May 1-6, • 2004

Adderall XR dosed once daily in adult patients with ADHD

RH Weisler, J Biederman, T Spencer
Presentation at: the 156th Annual Meeting of the American Psychiatric Association; May 20, • 2003

Longer term effects of stimulant treatments for Attention-Deficit/Hyperactivity Disorder

P. Jensen
J Atten Disord. 2002;6(suppl 1):S45-S56 • 2002

Similar Papers

Loading similar papers…